Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey

Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey

Bibliographic Details
Main Authors:	Maria Laura Canale, Fabio Turazza, Chiara Lestuzzi, Iris Parrini, Andrea Camerini, Giulia Russo, Furio Colivicchi, Domenico Gabrielli, Michele Massimo Gulizia, Stefano Oliva, Luigi Tarantini, Nicola Maurea, Luigi Rigacci, Sandro Petrolati, Giancarlo Casolo, Irma Bisceglia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	cardio-oncology anthracyclines trastuzumab global longitudinal strain cardiac biomarker healthcare
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.920605/full

Similar Items

Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
by: Maria Laura Canale, et al.
Published: (2021-06-01)

Women at heart: Introducing gender cardio-oncology
by: Maria Laura Canale, et al.
Published: (2022-11-01)

ANMCO (Italian Association of Hospital Cardiologists) scientific statement: obesity in adults—an approach for cardiologists
by: Stefania Angela Di Fusco, et al.
Published: (2024-01-01)

Associazione Nazionale Archeologi
by: Marina Maria Serena Nuovo, et al.
Published: (2022-04-01)

Trialogue. Managing hyperglycaemia in internal medicine. Instructions for use: Consensus document of the Associazione Medici Diabetologi (AMD), Federazione delle Associazioni dei Dirigenti Ospedalieri Internisti (FADOI) and Società Italiana di Diabetologi
by: Giampietro Beltramello, et al.
Published: (2013-03-01)

Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story
by: Irma Bisceglia, et al.
Published: (2023-03-01)

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
by: Irma Bisceglia, et al.
Published: (2022-01-01)

Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
by: Irma Bisceglia, et al.
Published: (2022-05-01)

HOW TO PUT CARDIO-ONCOLOGY REHABILITATION (CORE) IN DAILY CLINICAL PRACTICE. BENEFITS, INDICATIONS, BARRIERS AND POSSIBLE SOLUTIONS
by: Chiara Lestuzzi, et al.
Published: (2023-06-01)

Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
by: Andia Taghdiri
Published: (2024-06-01)

Hyaluronic Acid-Based Nanoparticles Loaded with Rutin as Vasculo-Protective Tools against Anthracycline-Induced Endothelial Damages
by: Carla Serri, et al.
Published: (2024-07-01)

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
by: S. Slavcheva
Published: (2024-05-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Genetics of Anthracycline-Associated Cardiotoxicity
by: Talal Khalid Al-Otaibi, et al.
Published: (2022-04-01)

Survivorship clinic attendance improves completion but not timeliness of cardiac surveillance post anthracyclines
by: Zac Forbes, et al.
Published: (2025-02-01)

XXXI Convegno Nazionale dell’Associazione Italiana Veterinari Igienisti (AIVI)| Teramo, 22-24 settembre 2022
by: the Editors
Published: (2022-09-01)

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey
by: Massimiliano Camilli, et al.
Published: (2023-08-01)

Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
by: John Lee, et al.
Published: (2024-12-01)

Comprehensive Analysis of Transcriptomics and Genetic Alterations Identifies Potential Mechanisms Underlying Anthracycline Therapy Resistance in Breast Cancer
by: Zihao Liu, et al.
Published: (2022-12-01)

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline‐Based Chemotherapy
by: David L. DeRemer, et al.
Published: (2023-05-01)

Cardiotoxicity: Importance of biomarkers
by: Kostadinović Jelena, et al.
Published: (2023-01-01)

Treatment related acute promyelocytic leukemia (t-APML) in breast cancer survivor treated with anthracycline based chemotherapy: rare case report
by: Irappa Madabhavi, et al.
Published: (2016-02-01)

Echocardiographic Changes after Treatment with Anthracyclines in Children
by: Hamid Amoozgar, et al.
Published: (2012-03-01)

Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study
by: Prathana Nathan, et al.
Published: (2022-12-01)

Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer
by: Azra Rašić, et al.
Published: (2019-02-01)

An Electron Transfer Approach to the Preparation of Highly Functionalized Anthraquinones
by: Patrice Vanelle, et al.
Published: (2005-01-01)

Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know
by: Armando Ferrera, et al.
Published: (2023-05-01)

Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis
by: Hao Jin, et al.
Published: (2023-01-01)

Editorial: Novel mechanisms, imaging approaches, and management strategies for anthracycline-induced cardiotoxicity
by: René R. Sevag Packard, et al.
Published: (2023-01-01)

XXXIII Convegno Nazionale dell’Associazione Italiana Veterinari Igienisti (AIVI) | Castellammare di Stabia, 11-13 Settembre 2024
by: the Editors
Published: (2024-09-01)

Associazione ILSA
by: Maggini, Massimo
Published: (2015-11-01)

Previous treatment with anthracycline does not affect the course of sepsis in cancer patients: Retrospective cohort study
by: Camille Windsor, et al.
Published: (2025-01-01)

CIRCULATION MICRORNA AS A POSSIBLE PREDICTOR OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: Maria Vladimirovna Khutornaya, et al.
Published: (2023-09-01)

Functional investigation of the SAM-dependent methyltransferase RdmB in anthracycline biosynthesis
by: Moli Sang, et al.
Published: (2025-01-01)

Acute myeloid leukemia presenting with hepatic dysfunction: Should induction be dose reduced?
by: Satish Maharaj, et al.
Published: (2024-10-01)

Can pharmacogenetics impact the therapeutic effect of cytarabine and anthracyclines in adult acute myeloid leukaemia patients?: A Serbian experience
by: Pravdić Zlatko, et al.
Published: (2024-01-01)

Left Ventricular Longitudinal Strain Abnormalities in Childhood Exposure to Anthracycline Chemotherapy
by: Arnaud Rique, et al.
Published: (2024-03-01)

Predictive Factors of Therapy-Related Cardiovascular Events in Patients with Lymphoma Receiving Anthracyclines
by: Alberto Lopez-Garcia, et al.
Published: (2024-04-01)

Orthogonality in Principal Component Analysis Allows the Discovery of Lipids in the Jejunum That Are Independent of Ad Libitum Feeding
by: David Balgoma, et al.
Published: (2022-09-01)

Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay
by: Leonardo Schirone, et al.
Published: (2022-06-01)